Transaction In Own Shares
| Date of Purchase | Aggregate number of ordinary shares purchased | Volume weighted average price (GB pence) | Highest Price per share (GB pence) | Lowest Price per share (GB pence) | Trading venue |
| 30 September 2026 | 22,000 | 3,647.5156 | 3,686.00 | 3,620.00 | London Stock Exchange |
| 30 September 2026 | 19,000 | 3,642.0444 | 3,684.00 | 3,620.00 | BATS Europe |
| 30 September 2026 | 6,000 | 3,642.8340 | 3,680.00 | 3,622.00 | Chi-X Europe |
| 30 September 2026 | 3,000 | 3,643.1220 | 3,674.00 | 3,622.00 | Aquis |
| 01 October 2026 | 22,126 | 3580.7399 | 3596.00 | 3554.00 | London Stock Exchange |
| 01 October 2026 | 18,874 | 3579.9839 | 3596.00 | 3558.00 | BATS Europe |
| 01 October 2026 | 6,000 | 3580.2047 | 3592.00 | 3564.00 | Chi-X Europe |
| 01 October 2026 | 3,000 | 3580.6727 | 3592.00 | 3564.00 | Aquis |
| 02 October 2026 | 22,737 | 3,600.4567 | 3,632.00 | 3,580.00 | London Stock Exchange |
| 02 October 2026 | 18,442 | 3,598.0853 | 3,632.00 | 3,574.00 | BATS Europe |
| 02 October 2026 | 5,821 | 3,597.7007 | 3,624.00 | 3,578.00 | Chi-X Europe |
| 02 October 2026 | 3,000 | 3,597.3713 | 3,624.00 | 3,576.00 | Aquis |
| 05 October 2026 | 22,125 | 3601.6494 | 3622.00 | 3576.00 | London Stock Exchange |
| 05 October 2026 | 18,913 | 3602.7581 | 3622.00 | 3576.00 | BATS Europe |
| 05 October 2026 | 5,667 | 3602.9642 | 3626.00 | 3580.00 | Chi-X Europe |
| 05 October 2026 | 3,295 | 3602.7781 | 3616.00 | 3574.00 | Aquis |
| 06 October 2026 | 22,084 | 3616.5730 | 3658.00 | 3590.00 | London Stock Exchange |
| 06 October 2026 | 19,013 | 3616.5150 | 3656.00 | 3592.00 | BATS Europe |
| 06 October 2026 | 5,617 | 3616.6028 | 3656.00 | 3588.00 | Chi-X Europe |
| 06 October 2026 | 3,286 | 3615.6762 | 3654.00 | 3594.00 | Aquis |
The Company intends to cancel all of the purchased ordinary shares.
Following the cancellation of the repurchased shares reported above, the Company's issued share capital will consist of 306,054,676 ordinary shares with voting rights.
There are no ordinary shares held in Treasury.
The above figure (306,054,676) may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's under the FCA's Disclosure Guidance and Transparency Rules.
From the commencement of the share buy-back programme on 30 September 2026, the Company has purchased 250,000 ordinary shares in aggregate at a weighted average price of 3,608.57p per ordinary share.
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended, a full breakdown of the individual purchases of ordinary shares made by UBS on behalf of the Company can be found in the link to this announcement.
Schedule of purchases - 30.06.26 - 06.10.26
- ENDS -
For further information, please contact:
Media:
Sian Broad ...
Investors/ Analysts:
Jelena Bjelanovic ...
Attachment
-
Schedule of purchases - 30.06.26 - 06.10.26
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment